Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER

Civil Hospices of Lyon

Status: Active, not recruiting

Conditions: CoV2 Positive Caregivers

Treatments: Diagnostic Test: Serological tests will be applied on patients blood sampling

Study type: Interventional

Funder types: Other

Identifiers

NCT04341142

69HCL20_0329

Details and patient eligibility

About

Covid-SER is a prospective multi-center study for the evaluation of diagnostic performance of available serological tests

Enrollment: 550 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Seropositive caregivers screened for anti-SARS CoV2 antibodies during their consultation at the occupational medicine of HCL.
• Age: ≥ 18 years old
• Persons having given their written consent and accepting a follow-up every 6 months for 24 months, followed by a final visit at 36 months.
• Persons affiliated to a social security scheme or beneficiary of such a scheme.

Exclusion criteria

• Pregnant or lactating woman

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

550 participants in 1 patient group

Serological tests will be applied on patients blood sampling

Experimental group

Description:

Serological tests will be applied on patients blood sampling

Treatment:

Diagnostic Test: Serological tests will be applied on patients blood sampling